Your browser doesn't support javascript.
loading
Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational Cohort.
Malespin, Miguel H; Barritt, Alfred Sidney; Watkins, Stephanie E; Schoen, Cheryl; Tincopa, Monica A; Corbin, Karen D; Mospan, Andrea R; Munoz, Breda; Trinh, Huy N; Weiss, L Michael; Reddy, K Rajender; Loomba, Rohit; Kemmer, Nyingi; Lok, Anna S.
Afiliação
  • Malespin MH; Tampa General Hospital, Tampa, Florida.
  • Barritt AS; Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Watkins SE; TARGET RWE, Durham, North Carolina.
  • Schoen C; TARGET RWE, Durham, North Carolina.
  • Tincopa MA; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
  • Corbin KD; AdventHealth Translational Research Institute, Orlando, Florida.
  • Mospan AR; TARGET RWE, Durham, North Carolina.
  • Munoz B; TARGET RWE, Durham, North Carolina.
  • Trinh HN; San Jose Gastroenterology, San Jose, California.
  • Weiss LM; Gastro Florida, Clearwater, Florida.
  • Reddy KR; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Loomba R; NAFLD Research Center, Division of Gastroenterology, Department of Medicine, University of California at San Diego, San Diego, California.
  • Kemmer N; Tampa General Hospital, Tampa, Florida.
  • Lok AS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan. Electronic address: aslok@med.umich.edu.
Clin Gastroenterol Hepatol ; 20(10): 2393-2395.e4, 2022 Oct.
Article em En | MEDLINE | ID: mdl-33486083
ABSTRACT
First-line treatment for nonalcoholic fatty liver disease (NAFLD) focuses on weight loss through lifestyle modifications.1,2 Weight loss ≥5% results in reduction of steatosis and weight loss ≥10% has been associated with improvement in hepatic inflammation and fibrosis.3 The incidence and sustainability of weight loss among patients with NAFLD were estimated and associating factors identified.
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article